We are partnering with the COVID-19 Vaccine Education and Equity Project to provide information about the regulatory review process and equitable distribution and access to COVID-19 vaccines. Learn more about getting your organization involved.

The New York Times has created a Coronavirus Vaccine Tracker that is updated regularly with information on the vaccine approval process, COVID-19 clinical trials, information on distribution and more.

Unsure of how the COVID-19 vaccine(s) will be rolled out in your state? See how and when you can get vaccinated.

SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn is a commentary published in the Annals of Internal Medicine by Drs. Conners, Graham, Lane, and Fauci, on what we have accomplished and what remains left to be learned in our COVID-19 vaccine efforts.

Covid-19 Vaccine Matters is a blog series discussing the evolving science and policy of COVID-19 vaccines, led by internationally renowned experts in vaccine development, Dr. Larry Corey of the University of Washington and Dr. Chris Beyrer of Johns Hopkins University.

The important perspectives of nursing in health issues can be amplified by local newspapers and newscasts. ANAC Member Anthony Valesco, MS, APRN, ACRN recently had a commentary published in the Palm Springs, CA local paper Desert Sun entitled Voice: Nurses can help get vaccines in arms and out of freezers in Riverside County.

Join the University of Washington School of Nursing and Johns Hopkins University School of Nursing on Wednesday, Feb. 24, 2020, 1-3 p.m. EST for a virtual COVID-19 Vaccination Symposium. Mission Possible: the vital role nurses play in the race to vaccinate includes leading experts who will share their in-depth knowledge of the logistical, medical and other details of the COVID-19 vaccination program.

Multiple SARS-CoV-2 variants are circulating globally. The CDC has been following the Emerging SARS-CoV-2 Variants and following the impact SARS-CoV-2 variants may have on transmission, treatments and vaccination. View a map showing the number of confirmed cases in each state of the new COVID-19 variants in the United States.

The COVID-19 Real-Time Learning Network provides a curated review of key information and literature about post COVID/long COVID.

The National Institute of Allergy and Infectious Diseases hosted a virtual Workshop on Post-Acute Sequelae of COVID-19 on Dec. 3-4, 2020 to summarize existing knowledge on post-acute manifestations of COVID-19 and to identify key knowledge gaps.

The NIH launched a database to track neurological symptoms associated with COVID-19. The COVID-19 Neuro Databank/Biobank (NeuroCOVID) is a resource of clinical information from people of all ages who have experienced neurological problems associated with SARS-CoV-2 infection. Health care providers are invited to use the web-based data portal to submit de-identified information.

The National Institute of Allergy and Infectious Diseases is conducting and supporting clinical research in response to the COVID-19 pandemic. COVID-19 Clinical Research is an information hub about research in understanding, preventing and treating SARS-CoV-2.

The HIV Medicine Association and the Infectious Diseases Society of America developed a COVID-19 Vaccines and People with HIV Frequently Asked Questions document to respond to questions from HIV clinicians, and as a resource for HIV clinicians to respond to patient questions regarding COVID-19 vaccines.

Two recent papers explore the intersection between COVID-19 and HIV and report that due to parallel co-morbidities and/or structural inequities, some people living with HIV may have worse COVID-19 outcomes.

Treatment Action Group has compiled COVID-19 resources focused on engaging diverse communities, including persons living with HIV.